about
Redox mechanisms in hepatic chronic wound healing and fibrogenesisNon-alcoholic fatty liver disease: a practical approach to diagnosis and stagingThe genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular modelNovel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfaWhole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcomeDiagnosis, management, and treatment of hepatitis C: an updateAn update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in JapanUnique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control.Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 TMitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in micePitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis BWild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses.Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionLong-term effects of antiviral therapy in patients with chronic hepatitis C.Liver biopsy for histological assessment: The case in favorFemale hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan.Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden miceAssessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy.Iron deposition and fat accumulation in dimethylnitrosamine-induced liver fibrosis in rat.Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis BResistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cellsThiazolidinediones and hepatic fibrosis: don't wait too long.Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.Body mass index and risk of primary liver cancer: a meta-analysis of prospective studiesHepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding ProteinHepatitis C virus utilizes lipid droplet for production of infectious virus.The evolving role of leptin and adiponectin in chronic liver diseases.Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin.Histological assessment of non-alcoholic fatty liver disease.New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.Current concepts in the pathogenesis of nonalcoholic fatty liver disease.Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.Pathology of fatty liver disease.Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals.
P2860
Q24656684-E0FC0B39-BF3F-46E2-9324-927E50B3322EQ27006131-5EC05207-1F12-4FF5-B8FF-C7D03301EE2AQ27485480-665ECA63-325A-45BE-AC54-96CA7F2EB9FFQ28076525-96AB685B-0CDB-4380-BD22-76E2527E46C8Q28542460-456064CD-285B-4C54-8529-4B311F5134FDQ29619682-34E1C023-0A31-4CC7-BD2B-D89462FB692CQ30453975-B41C822A-3AEA-46BA-A897-C5B1B5564A5BQ30478139-380BA01C-21F5-4CA6-8165-2C77878EBB48Q33569618-2632C482-3D85-4036-8DDC-003ECE657B7EQ33787851-F63E87A1-B63F-44DB-B8FC-BD7F63FA8216Q33861769-BB0F928B-199D-4A24-B532-B1D9A801C918Q33944911-CA658EA3-946F-4F19-81CC-64B6D97FA990Q34036808-536665F2-2DD5-40AA-9924-B920C39AD65AQ34040303-AF4FE7DF-F055-49B9-9DA6-A6A0D71D846EQ34263370-69C0B33E-CEDD-46AB-8E4E-FCCDFF5AB2FBQ34415157-9E427B4F-42E9-4B7A-9271-9932F3F04A9BQ34469014-65D2BDD3-2A38-4A2B-ABCB-281B9937F158Q34606036-B1529466-0650-48A2-8EE7-7B18E30F249CQ34635693-898040CE-109F-4C80-9166-6A507A4F5BADQ34670902-2CB0A63C-8BAC-415A-8F0F-3B98EE20481CQ34776315-623D4F94-6FB7-4B28-BF54-838C4D1A0E01Q34856251-17AEEFC3-7F5A-4C0A-B2CA-D0DA6AB2C136Q35055935-C9F8C307-F172-43C4-81C1-98CAF86489E9Q35155090-E48A039B-246D-4D1D-A9E7-0469F2AEFE0AQ35555702-8D4CB08B-0740-40A4-B15B-D247CEDB117DQ35569812-600AAB37-BA0D-41D0-952A-62D69243F829Q35760700-80A2A817-3B9D-4C63-AA80-9F6016F3E96FQ36026554-57C1AD0B-3532-4E79-8ED1-5BA80C37C935Q36330881-479DF016-C6D1-4331-9B0B-685FD9EE45FDQ36405672-2458F6E7-7576-4108-87E6-495098C05FBDQ36523963-9B1AC47A-0BFE-4284-9F10-E1BDF4F8BCDEQ36580492-2464776E-A7E1-4A42-87F7-CE7194FE7806Q36585280-059DBF01-1232-4176-B64C-34EB841F3477Q36588193-D9CAEFF1-1F3E-43FE-807C-96228A7BC2D5Q36634377-5860072F-CED1-4212-89B2-A21547F34079Q36740642-28125FB2-CB9A-4300-BC2C-5F488377B782Q36777932-C5A4862F-0189-484E-B5F7-DD69A079BB47Q36809695-C5C6C06F-AD39-471E-8593-9FB88039A5E7Q36814311-4CC659FF-0A75-42C6-ABEE-E1BCCFB31E31Q36871125-B5503157-27F4-460D-8563-4D7D2D9C8F95
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Steatosis: co-factor in other liver diseases.
@ast
Steatosis: co-factor in other liver diseases.
@en
type
label
Steatosis: co-factor in other liver diseases.
@ast
Steatosis: co-factor in other liver diseases.
@en
prefLabel
Steatosis: co-factor in other liver diseases.
@ast
Steatosis: co-factor in other liver diseases.
@en
P2860
P356
P1433
P1476
Steatosis: co-factor in other liver diseases
@en
P2093
Julie R Jonsson
P2860
P356
10.1002/HEP.20750
P407
P577
2005-07-01T00:00:00Z